Apoptosis, or programmed cell death, is an important process by which cells self-destruct in a regulated manner. During development, apoptosis sculpted structures like fingers and toes by killing cells between them. Apoptosis also causes tissues like the tail to disappear at metamorphosis. The process is mediated by caspase proteases and regulated by Bcl-2 family proteins, with Bax and Bak activating caspases. Cells undergo apoptosis to maintain tissue homeostasis, avoid harming neighbors, and be removed by macrophages.
Seminar about apoptosis a type of programmed cell death in Soran University by Mahmood Khaleel Pirani (MSc Student) for Medical Physiology lecture on 24 November 2018
Seminar about apoptosis a type of programmed cell death in Soran University by Mahmood Khaleel Pirani (MSc Student) for Medical Physiology lecture on 24 November 2018
Cell death, particularly apoptosis, is probably one of the
most widely-studied subjects among cell biologists.
Understanding apoptosis in disease conditions is very
important as it not only gives insights into the pathogenesis
of a disease but may also leaves clues on how
the disease can be treated. In cancer, there is a loss of
balance between cell division and cell death and cells
that should have died did not receive the signals to do
so. The problem can arise in any one step along the way
of apoptosis.Apoptosis is an ordered and orchestrated cellular process that occurs in physiological and pathological conditions.
It is also one of the most studied topics among cell biologists. An understanding of the underlying mechanism of
apoptosis is important as it plays a pivotal role in the pathogenesis of many diseases. In some, the problem is due
to too much apoptosis, such as in the case of degenerative diseases while in others, too little apoptosis is the
culprit. Cancer is one of the scenarios where too little apoptosis occurs, resulting in malignant cells that will not
die. The mechanism of apoptosis is complex and involves many pathways. Defects can occur at any point along
these pathways, leading to malignant transformation of the affected cells, tumour metastasis and resistance to
anticancer drugs. Despite being the cause of problem, apoptosis plays an important role in the treatment of
cancer as it is a popular target of many treatment strategies. The abundance of literature suggests that targeting
apoptosis in cancer is feasible. However, many troubling questions arise with the use of new drugs or treatment
strategies that are designed to enhance apoptosis and critical tests must be passed before they can be used safely
in human subjects.. It is used,
in contrast to necrosis, to describe the situation in
which a cell actively pursues a course toward death
upon receiving certain stimule
Cell death, particularly apoptosis, is probably one of the
most widely-studied subjects among cell biologists.
Understanding apoptosis in disease conditions is very
important as it not only gives insights into the pathogenesis
of a disease but may also leaves clues on how
the disease can be treated. In cancer, there is a loss of
balance between cell division and cell death and cells
that should have died did not receive the signals to do
so. The problem can arise in any one step along the way
of apoptosis.Apoptosis is an ordered and orchestrated cellular process that occurs in physiological and pathological conditions.
It is also one of the most studied topics among cell biologists. An understanding of the underlying mechanism of
apoptosis is important as it plays a pivotal role in the pathogenesis of many diseases. In some, the problem is due
to too much apoptosis, such as in the case of degenerative diseases while in others, too little apoptosis is the
culprit. Cancer is one of the scenarios where too little apoptosis occurs, resulting in malignant cells that will not
die. The mechanism of apoptosis is complex and involves many pathways. Defects can occur at any point along
these pathways, leading to malignant transformation of the affected cells, tumour metastasis and resistance to
anticancer drugs. Despite being the cause of problem, apoptosis plays an important role in the treatment of
cancer as it is a popular target of many treatment strategies. The abundance of literature suggests that targeting
apoptosis in cancer is feasible. However, many troubling questions arise with the use of new drugs or treatment
strategies that are designed to enhance apoptosis and critical tests must be passed before they can be used safely
in human subjects.. It is used,
in contrast to necrosis, to describe the situation in
which a cell actively pursues a course toward death
upon receiving certain stimule
Hi! I am Komal Sankaran, M.Sc. Biotechnology (Pune University Gold Medalist, 2013), CSIR-NET SPM fellow (Jun- 2014, 4th rank), CSIR-NET- LS (Dec 2013, 2nd rank), DBT JRF category- I. Please contact if anyone is interested in Life Sciences CSIR-NET coaching in Pune (Khadki area).
Email- komalsan91@gmail.com
Content-
1. Background
2. Introduction
3. Difference between apoptosis and necrosis
4. Apoptosis in biologic processes
5. Apoptosis in pathologic processes
6. Morphologic features
7. Techniques to identify and count apoptotic cells
8. Biochemical changes
9. Molecular mechanism of apoptosis
10. Recent advancement and emerging trends in apoptosis
11. References
Cancer cell metabolism: special Reference to Lactate PathwayAADYARAJPANDEY1
Normal Cell Metabolism:
Cellular respiration describes the series of steps that cells use to break down sugar and other chemicals to get the energy we need to function.
Energy is stored in the bonds of glucose and when glucose is broken down, much of that energy is released.
Cell utilize energy in the form of ATP.
The first step of respiration is called glycolysis. In a series of steps, glycolysis breaks glucose into two smaller molecules - a chemical called pyruvate. A small amount of ATP is formed during this process.
Most healthy cells continue the breakdown in a second process, called the Kreb's cycle. The Kreb's cycle allows cells to “burn” the pyruvates made in glycolysis to get more ATP.
The last step in the breakdown of glucose is called oxidative phosphorylation (Ox-Phos).
It takes place in specialized cell structures called mitochondria. This process produces a large amount of ATP. Importantly, cells need oxygen to complete oxidative phosphorylation.
If a cell completes only glycolysis, only 2 molecules of ATP are made per glucose. However, if the cell completes the entire respiration process (glycolysis - Kreb's - oxidative phosphorylation), about 36 molecules of ATP are created, giving it much more energy to use.
IN CANCER CELL:
Unlike healthy cells that "burn" the entire molecule of sugar to capture a large amount of energy as ATP, cancer cells are wasteful.
Cancer cells only partially break down sugar molecules. They overuse the first step of respiration, glycolysis. They frequently do not complete the second step, oxidative phosphorylation.
This results in only 2 molecules of ATP per each glucose molecule instead of the 36 or so ATPs healthy cells gain. As a result, cancer cells need to use a lot more sugar molecules to get enough energy to survive.
Unlike healthy cells that "burn" the entire molecule of sugar to capture a large amount of energy as ATP, cancer cells are wasteful.
Cancer cells only partially break down sugar molecules. They overuse the first step of respiration, glycolysis. They frequently do not complete the second step, oxidative phosphorylation.
This results in only 2 molecules of ATP per each glucose molecule instead of the 36 or so ATPs healthy cells gain. As a result, cancer cells need to use a lot more sugar molecules to get enough energy to survive.
introduction to WARBERG PHENOMENA:
WARBURG EFFECT Usually, cancer cells are highly glycolytic (glucose addiction) and take up more glucose than do normal cells from outside.
Otto Heinrich Warburg (; 8 October 1883 – 1 August 1970) In 1931 was awarded the Nobel Prize in Physiology for his "discovery of the nature and mode of action of the respiratory enzyme.
WARNBURG EFFECT : cancer cells under aerobic (well-oxygenated) conditions to metabolize glucose to lactate (aerobic glycolysis) is known as the Warburg effect. Warburg made the observation that tumor slices consume glucose and secrete lactate at a higher rate than normal tissues.
The increased availability of biomedical data, particularly in the public domain, offers the opportunity to better understand human health and to develop effective therapeutics for a wide range of unmet medical needs. However, data scientists remain stymied by the fact that data remain hard to find and to productively reuse because data and their metadata i) are wholly inaccessible, ii) are in non-standard or incompatible representations, iii) do not conform to community standards, and iv) have unclear or highly restricted terms and conditions that preclude legitimate reuse. These limitations require a rethink on data can be made machine and AI-ready - the key motivation behind the FAIR Guiding Principles. Concurrently, while recent efforts have explored the use of deep learning to fuse disparate data into predictive models for a wide range of biomedical applications, these models often fail even when the correct answer is already known, and fail to explain individual predictions in terms that data scientists can appreciate. These limitations suggest that new methods to produce practical artificial intelligence are still needed.
In this talk, I will discuss our work in (1) building an integrative knowledge infrastructure to prepare FAIR and "AI-ready" data and services along with (2) neurosymbolic AI methods to improve the quality of predictions and to generate plausible explanations. Attention is given to standards, platforms, and methods to wrangle knowledge into simple, but effective semantic and latent representations, and to make these available into standards-compliant and discoverable interfaces that can be used in model building, validation, and explanation. Our work, and those of others in the field, creates a baseline for building trustworthy and easy to deploy AI models in biomedicine.
Bio
Dr. Michel Dumontier is the Distinguished Professor of Data Science at Maastricht University, founder and executive director of the Institute of Data Science, and co-founder of the FAIR (Findable, Accessible, Interoperable and Reusable) data principles. His research explores socio-technological approaches for responsible discovery science, which includes collaborative multi-modal knowledge graphs, privacy-preserving distributed data mining, and AI methods for drug discovery and personalized medicine. His work is supported through the Dutch National Research Agenda, the Netherlands Organisation for Scientific Research, Horizon Europe, the European Open Science Cloud, the US National Institutes of Health, and a Marie-Curie Innovative Training Network. He is the editor-in-chief for the journal Data Science and is internationally recognized for his contributions in bioinformatics, biomedical informatics, and semantic technologies including ontologies and linked data.
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...Sérgio Sacani
We characterize the earliest galaxy population in the JADES Origins Field (JOF), the deepest
imaging field observed with JWST. We make use of the ancillary Hubble optical images (5 filters
spanning 0.4−0.9µm) and novel JWST images with 14 filters spanning 0.8−5µm, including 7 mediumband filters, and reaching total exposure times of up to 46 hours per filter. We combine all our data
at > 2.3µm to construct an ultradeep image, reaching as deep as ≈ 31.4 AB mag in the stack and
30.3-31.0 AB mag (5σ, r = 0.1” circular aperture) in individual filters. We measure photometric
redshifts and use robust selection criteria to identify a sample of eight galaxy candidates at redshifts
z = 11.5 − 15. These objects show compact half-light radii of R1/2 ∼ 50 − 200pc, stellar masses of
M⋆ ∼ 107−108M⊙, and star-formation rates of SFR ∼ 0.1−1 M⊙ yr−1
. Our search finds no candidates
at 15 < z < 20, placing upper limits at these redshifts. We develop a forward modeling approach to
infer the properties of the evolving luminosity function without binning in redshift or luminosity that
marginalizes over the photometric redshift uncertainty of our candidate galaxies and incorporates the
impact of non-detections. We find a z = 12 luminosity function in good agreement with prior results,
and that the luminosity function normalization and UV luminosity density decline by a factor of ∼ 2.5
from z = 12 to z = 14. We discuss the possible implications of our results in the context of theoretical
models for evolution of the dark matter halo mass function.
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...Sérgio Sacani
Since volcanic activity was first discovered on Io from Voyager images in 1979, changes
on Io’s surface have been monitored from both spacecraft and ground-based telescopes.
Here, we present the highest spatial resolution images of Io ever obtained from a groundbased telescope. These images, acquired by the SHARK-VIS instrument on the Large
Binocular Telescope, show evidence of a major resurfacing event on Io’s trailing hemisphere. When compared to the most recent spacecraft images, the SHARK-VIS images
show that a plume deposit from a powerful eruption at Pillan Patera has covered part
of the long-lived Pele plume deposit. Although this type of resurfacing event may be common on Io, few have been detected due to the rarity of spacecraft visits and the previously low spatial resolution available from Earth-based telescopes. The SHARK-VIS instrument ushers in a new era of high resolution imaging of Io’s surface using adaptive
optics at visible wavelengths.
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.Sérgio Sacani
The return of a sample of near-surface atmosphere from Mars would facilitate answers to several first-order science questions surrounding the formation and evolution of the planet. One of the important aspects of terrestrial planet formation in general is the role that primary atmospheres played in influencing the chemistry and structure of the planets and their antecedents. Studies of the martian atmosphere can be used to investigate the role of a primary atmosphere in its history. Atmosphere samples would also inform our understanding of the near-surface chemistry of the planet, and ultimately the prospects for life. High-precision isotopic analyses of constituent gases are needed to address these questions, requiring that the analyses are made on returned samples rather than in situ.
Multi-source connectivity as the driver of solar wind variability in the heli...Sérgio Sacani
The ambient solar wind that flls the heliosphere originates from multiple
sources in the solar corona and is highly structured. It is often described
as high-speed, relatively homogeneous, plasma streams from coronal
holes and slow-speed, highly variable, streams whose source regions are
under debate. A key goal of ESA/NASA’s Solar Orbiter mission is to identify
solar wind sources and understand what drives the complexity seen in the
heliosphere. By combining magnetic feld modelling and spectroscopic
techniques with high-resolution observations and measurements, we show
that the solar wind variability detected in situ by Solar Orbiter in March
2022 is driven by spatio-temporal changes in the magnetic connectivity to
multiple sources in the solar atmosphere. The magnetic feld footpoints
connected to the spacecraft moved from the boundaries of a coronal hole
to one active region (12961) and then across to another region (12957). This
is refected in the in situ measurements, which show the transition from fast
to highly Alfvénic then to slow solar wind that is disrupted by the arrival of
a coronal mass ejection. Our results describe solar wind variability at 0.5 au
but are applicable to near-Earth observatories.
2. Apoptosis helps regulate animal cell numbers
If cells are no longer needed, they can commit
suicide by activating an intracellular death
program—a process called programmed cell death.
In animals, by far the most common form of
programmed cell death is called apoptosis (Greek
word meaning ‘falling off,’)
A form of cell death in which a programmed
sequence of events leads to the elimination of
cells without releasing harmful substances into
the surrounding area.
3.
4. What purposes does this massive
cell suicide serve?
Mouse paws—and our own hand and feet—are
sculpted by apoptosis during embryonic
development: they start out as spade like structures,
and the individual fingers and toes separate because
the cells between them die
When a tadpole changes into a frog at
metamorphosis, the cells in the tail die, and the tail,
which is not needed in the frog, disappears
5. Cell death usually exactly balances cell
division, unless the tissue is growing or
shrinking
Eg. If part of the liver is removed in an adult rat,
for example, liver cells proliferate to make up the
loss. Conversely, if a rat is treated with the drug
phenobarbital, which stimulates liver cell division,
the liver enlarges.
However, when the phenobarbital treatment is
stopped, apoptosis in the liver greatly increases
until the organ has returned to its original size,
usually within a week or so. Thus, the liver is kept
at a constant size through regulation of both the
cell death rate and the cell birth rate.
6. Cell that undergoes apoptosis dies
neatly, without damaging its
neighbours.
cytoskeleton collapses, the nuclear envelope
disassembles, and the nuclear DNA breaks up
into fragments.
macrophages – cells engulf the apoptotic cell
before it spills its contents
destructive and self-amplifying but also
irreversible
7. Machinery that is responsible for
apoptosis
involves the caspase family of proteases - made
as inactive precursors called procaspases.
apoptosis is mediated by an intracellular
proteolytic cascade.
8.
9. Death program is regulated by the
bcl2 family of intracellular proteins
All nucleated animal cells - inactive procaspases
lie waiting for a signal to destroy the cell.
main proteins that regulate the activation of
procaspases are members of the Bcl2 family
Some members of this protein family promote
procaspase activation and cell death, whereas
others inhibit these processes.
most important death-promoting family members
are proteins called Bax and Bak.
10. Bax and Bak.
These proteins activate procaspases indirectly, by
inducing the release of cytochrome c from
mitochondria into the cytosol.
Cytochrome c promotes the assembly of a large,
seven-armed pinwheel-like structure that recruits
specific procaspase molecules, forming a protein
complex called an apoptosome.
The procaspase molecules become activated within
the apoptosome, triggering a caspase cascade that
leads to apoptosis
Bax and Bak proteins are themselves activated by
other death-promoting members of the Bcl2 family,
11.
12. Extracellular signals to survive,
Grow, and divide
Most of the extracellular signal molecules that influence
cell survival, cell growth, and cell division are either
soluble proteins secreted by other cells or proteins bound
to the surface of other cells or the extracellular matrix.
Three major categories:
1. Survival factors promote cell survival, largely by
suppressing apoptosis.
2. Mitogens stimulate cell division, primarily by overcoming
the intracellular braking mechanisms that tend to block
progression through the cell cycle.
3. Growth factors stimulate cell growth (an increase in cell
size and mass) by promoting the synthesis and inhibiting
the degradation of proteins and other macromolecules.
13. Survival factors to avoid
apoptosis
signals from other cells helps to ensure that cells
survive only when and where they are needed
Survival factors usually act by binding to cell-surface
receptors.
These activated receptors then turn on intracellular
signaling pathways that keep the death program
suppressed, usually by regulating members of the
Bcl2 family of proteins.
Some survival factors, for example, increase the
production of Bcl2, a protein that suppresses
apoptosis
14.
15. Pathways
The Extrinsic Pathway:
In the extrinsic pathway, signal molecules known as ligands, which
are released by other cells, bind to transmembrane death receptors
on the target cell to induce apoptosis.
For example, the immune system’s natural killer cells possess the
Fas ligand (FasL) on their surface .
The binding of the FasL to Fas receptors (a death receptor) on the
target cell will trigger multiple receptors to aggregate together on the
surface of the target cell.
The aggregation of these receptors recruits an adaptor protein
known as Fas-associated death domain protein (FADD) on the
cytoplasmic side of the receptors.
FADD, in turn, recruits caspase-8, an initiator protein, to form the
death-inducing signal complex (DISC).
Through the recruitment of caspase-8 to DISC, caspase-8 will be
activated and it is now able to directly activate caspase-3, an effector
protein, to initiate degradation of the cell.
Active caspase-8 can also cleave BID protein to tBID, which acts as
a signal on the membrane of mitochondria to facilitate the release of
cytochrome c in the intrinsic pathway.
16. The Intrinsic Pathway:
The intrinsic pathway is triggered by cellular stress, specifically
mitochondrial stress caused by factors such as DNA damage
and heat shock.
Upon receiving the stress signal, the proapoptotic proteins in
the cytoplasm, BAX and BID, bind to the outer membrane of
the mitochondria to signal the release of the internal content.
However, the signal of BAX and BID is not enough to trigger a
full release. BAK, another proapoptotic protein that resides
within the mitochondria, is also needed to fully promote the
release of cytochrome c and the intramembrane content from
the mitochondria.
Following the release, cytochrome c forms a complex in the
cytoplasm with adenosine triphosphate (ATP), an energy
molecule, and Apaf-1, an enzyme.
Following its formation, the complex will activate caspase-9,
an initiator protein.
In return, the activated caspase-9 works together with the
complex of cytochrome c, ATP and Apaf-1 to form an
apoptosome, which in turn activates caspase-3, the effector
protein that initiates degradation.
Besides the release of cytochrome c from the intramembrane